全文获取类型
收费全文 | 1595篇 |
免费 | 93篇 |
国内免费 | 113篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 70篇 |
妇产科学 | 15篇 |
基础医学 | 201篇 |
口腔科学 | 30篇 |
临床医学 | 203篇 |
内科学 | 394篇 |
皮肤病学 | 43篇 |
神经病学 | 53篇 |
特种医学 | 367篇 |
外国民族医学 | 1篇 |
外科学 | 70篇 |
综合类 | 43篇 |
预防医学 | 116篇 |
眼科学 | 15篇 |
药学 | 103篇 |
中国医学 | 1篇 |
肿瘤学 | 75篇 |
出版年
2021年 | 13篇 |
2020年 | 7篇 |
2019年 | 12篇 |
2018年 | 21篇 |
2017年 | 7篇 |
2016年 | 20篇 |
2015年 | 25篇 |
2014年 | 28篇 |
2013年 | 40篇 |
2012年 | 23篇 |
2011年 | 38篇 |
2010年 | 58篇 |
2009年 | 53篇 |
2008年 | 37篇 |
2007年 | 81篇 |
2006年 | 40篇 |
2005年 | 66篇 |
2004年 | 20篇 |
2003年 | 17篇 |
2002年 | 23篇 |
2001年 | 21篇 |
2000年 | 28篇 |
1999年 | 24篇 |
1998年 | 97篇 |
1997年 | 99篇 |
1996年 | 108篇 |
1995年 | 66篇 |
1994年 | 64篇 |
1993年 | 64篇 |
1992年 | 16篇 |
1991年 | 34篇 |
1990年 | 27篇 |
1989年 | 53篇 |
1988年 | 47篇 |
1987年 | 67篇 |
1986年 | 35篇 |
1985年 | 47篇 |
1984年 | 23篇 |
1983年 | 17篇 |
1982年 | 27篇 |
1981年 | 24篇 |
1980年 | 35篇 |
1979年 | 14篇 |
1978年 | 17篇 |
1977年 | 19篇 |
1976年 | 27篇 |
1975年 | 18篇 |
1972年 | 8篇 |
1969年 | 5篇 |
1967年 | 6篇 |
排序方式: 共有1801条查询结果,搜索用时 78 毫秒
61.
A new quantitative immunoperoxidase method is presented for determining absolute amounts of peroxidase and, consequently, surface antigen densities of individual cells in B lymphocytes from normal individuals, from subjects with CLL and prolymphocytic leukemia, and during ontogeny of B lympocytes in the mouse. The following results were observed: (1) The density of B antigenic sites were lower on CLL than on normal B lymphocytes. (2) The B antigens density of leukemic lymphocytes varied less from cell to cell, forming a homogeneous peak on histograms. (3) In a very rare case of CLL, the antigen density was measured at the time of initial diagnosis (22,500 sites or 647 U) and during the development of a blastic crisis (135,000 sites or 2576 U). The cell by cell distribution changed from a homogeneous peak with a low number of antigenic sites per cell to a heterogeneous peak with a high number of antigenic sites per cell. (4) In prolymphocytic leukemia, the density of B antigenic sites was greater than on normal B lymphocytes and much more heterogeneous than on CLL lymphocytes. (5) During ontogeny of B lymphocytes in the mouse, maturation is associated with the appearance of a population of cells of intermediate to high Smig density. The finding of a decrease in, and altered distribution of, surface markers in CLL is compared with these ontologic findings in the mouse, and the concept that a monoclonal B lymphocyte in CLL may be arrested at a particular stage in its differentiation is discussed. 相似文献
62.
63.
Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer
下载免费PDF全文
![点击此处可从《BJU international》网站下载免费的PDF全文](/ch/ext_images/free.gif)
David R. Ziehr Ming‐Hui Chen Danjie Zhang Michelle H. Braccioforte Brian J. Moran Brandon A. Mahal Andrew S. Hyatt Shehzad S. Basaria Clair J. Beard Joshua A. Beckman Toni K. Choueiri Anthony V. D'Amico Karen E. Hoffman Jim C. Hu Neil E. Martin Christopher J. Sweeney Quoc‐Dien Trinh Paul L. Nguyen 《BJU international》2015,116(3):358-365
64.
65.
S Wurtzer V Marechal JM Mouchel Y Maday R Teyssou E Richard JL Almayrac L Moulin 《Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin》2020,25(50)
IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease (COVID-19). People infected with SARS-CoV-2 may exhibit no or mild non-specific symptoms; thus, they may contribute to silent circulation of the virus among humans. Since SARS-CoV-2 RNA can be detected in stool samples, monitoring SARS-CoV-2 RNA in waste water (WW) has been proposed as a complementary tool to investigate virus circulation in human populations.AimTo test if the quantification of SARS-CoV-2 genomes in WW correlates with the number of symptomatic or non-symptomatic carriers.MethodWe performed a time-course quantitative analysis of SARS-CoV-2 by RT-qPCR in raw WW samples collected from several major WW treatment plants in Greater Paris. The study period was 5 March to 23 April 2020, including the lockdown period in France (from 17 March).ResultsWe showed that the increase of genome units in raw WW accurately followed the increase of human COVID-19 cases observed at the regional level. Of note, the viral genome could be detected before the epidemic grew massively (around 8 March). Equally importantly, a marked decrease in the quantities of genome units was observed concomitantly with the reduction in the number of new COVID-19 cases, 29 days following the lockdown.ConclusionThis work suggests that a quantitative monitoring of SARS-CoV-2 genomes in WW could generate important additional information for improved monitoring of SARS-CoV-2 circulation at local or regional levels and emphasises the role of WW-based epidemiology. 相似文献
66.
67.
Measuring recall of medical information in non‐English‐speaking people with cancer: A methodology
下载免费PDF全文
![点击此处可从《Health expectations》网站下载免费的PDF全文](/ch/ext_images/free.gif)
68.
Stephania Donayre Pimentel Heather Adams Tamara Ellis Robin Clark Craig Sully Catherine Paré Michael JL. Sullivan 《Journal of traumatic stress》2020,33(5):731-740
Catastrophizing has been discussed as a cognitive precursor to the emergence of posttraumatic stress disorder (PTSD) symptoms following the experience of stressful events. Implicit in cognitive models of PTSD is that treatment-related reductions in catastrophizing should yield reductions in PTSD symptoms. The tenability of this prediction has yet to be tested. The present study investigated the sequential relation between changes in a specific form of catastrophizing—symptom catastrophizing—and changes in PTSD symptom severity in a sample of 73 work-disabled individuals enrolled in a 10-week behavioral activation intervention. Measures of symptom catastrophizing and PTSD symptom severity were completed at pre-, mid-, and posttreatment assessment points. Cross-sectional analyses of pretreatment data revealed that symptom catastrophizing accounted for significant variance in PTSD symptom severity, β = .40, p < .001, sr = .28 (medium effect size), even when controlling for known correlates of symptom catastrophizing, such as pain and depression. Significant reductions in symptom catastrophizing and PTSD symptoms were observed during treatment, with large effect sizes, ds = 1.42 and 0.94, respectively, ps < .001. Cross-lagged analyses revealed that early change in symptom catastrophizing predicted later change in PTSD symptoms; early changes in PTSD symptom severity did not predict later change in symptom catastrophizing. These findings are consistent with the conceptual models that posit a causal relation between catastrophizing and PTSD symptom severity. The clinical implications of the findings are discussed. 相似文献
69.
70.
Brandon A. Mahal David R. Ziehr Ayal A. Aizer Andrew S. Hyatt Jesse D. Sammon Marianne Schmid Toni K. Choueiri Jim C. Hu Christopher J. Sweeney Clair J. Beard Anthony V. D׳Amico Neil E. Martin Christopher Lathan Simon P. Kim Quoc-Dien Trinh Paul L. Nguyen 《Urologic oncology》2014,32(8):1285-1291
ObjectivesTreating high-risk prostate cancer (CaP) with definitive therapy improves survival. We evaluated whether having health insurance reduces racial disparities in the use of definitive therapy for high-risk CaP.Materials and methodsThe Surveillance, Epidemiology, and End Results Program was used to identify 70,006 men with localized high-risk CaP (prostate-specific antigen level >20 ng/ml or Gleason score 8–10 or stage>cT3a) diagnosed from 2007 to 2010. We used multivariable logistic regression to analyze the 64,277 patients with complete data to determine the factors associated with receipt of definitive therapy.ResultsCompared with white men, African American (AA) men were significantly less likely to receive definitive treatment (adjusted odds ratio [AOR] = 0.60; 95% CI: 0.56–0.64; P<0.001) after adjusting for sociodemographics and known CaP prognostic factors. There was a significant interaction between race and insurance status (Pinteraction = 0.01) such that insurance coverage was associated with a reduction in racial disparity between AA and white patients regarding receipt of definitive therapy. Specifically, the AOR for definitive treatment for AA vs. white was 0.38 (95% CI: 0.27–0.54, P<0.001) among uninsured men, whereas the AOR was 0.62 (95% CI: 0.57–0.66, P<0.001) among insured men.ConclusionsAA men with high-risk CaP were significantly less likely to receive potentially life-saving definitive treatment when compared with white men. Having health insurance was associated with a reduction in this racial treatment disparity, suggesting that expansion of health insurance coverage may help reduce racial disparities in the management of aggressive cancers. 相似文献